A pilot randomised controlled trial of acceptance and commitment therapy for medication decision‐making and quality of life in women with breast cancer: the action trial

HIGHLIGHTS

• What: This trial reported a signal of efficacy at 1 month follow‐up, but not for longer‐term efficacy . Prior to evaluating the intervention in a phase III trial, reason for non‐adherence to AET. Data will be shared for projects that are in the public interest across the trial arms. and compatible with the original purpose of the data processing. The trial was originally designed such that therapists from multiple sites would deliver the intervention.
• Who: - Revised and colleagues from the Leeds Institute of Health Science, University of Leeds, Leeds, UK have published the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.